1.31
Allogene Therapeutics Inc (ALLO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
4.64
|
- | - | - | - |
| Operating Expenses |
11.86%
51.56
|
46.09 | 42.40 | 44.90 | 56.82 |
| Operating Income/Loss |
1.80%
-46.92
|
-46.09 | -42.40 | -44.90 | -56.82 |
| Nonoperating Income/Loss |
21.75%
4.243
|
3.485 | 3.594 | 3.501 | 5.876 |
| Net Income/Loss |
0.16%
-42.68
|
-42.61 | -38.81 | -41.40 | -50.94 |
| Basic Average Shares |
36.89%
328.93
|
240.29 | - | 222.04 | 218.93 |
| Diluted Average Shares |
36.89%
328.93
|
240.29 | - | 222.04 | 218.93 |
| Basic Earnings Per Share |
27.78%
-0.13
|
-0.18 | - | -0.19 | -0.23 |
| Diluted Earnings Per Share |
27.78%
-0.13
|
-0.18 | - | -0.19 | -0.23 |
大文字化:
|
ボリューム (24 時間):